ATLAS Score for Clostridium Difficile Infection

ورودی‌های بالینی بیمار

پنل نتیجه و تصمیم بالینی
در انتظار ورودی‌ها
atlas score
—points
آماده برای ارزیابی

پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.

طبقات خطر و بازه‌های امتیاز:
  • —0–2
  • —3–6
Direct Clinical Answer

The ATLAS Score for Clostridium Difficile Infection calculates predicting response to therapy in C. Key inputs include age 65 or older. Scores guide administering empiric broad-spectrum antimicrobial regimens, infectious source control, and isolation protocols. This standardized assessment improves clinical decision safety and bedside patient management.

Clinical Guidelines & Evidence

Predicts response to therapy in C. diff patients

Clinical Indication

The ATLAS Score for Clostridium Difficile Infection is indicated for bedside clinical practice to support Predicts response to therapy in C. diff patients. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.

Target Population

Target population comprises Patients presenting with suspected sepsis, meningitis, pneumonia, COVID-19, opportunistic infections, or fever of unknown origin. Clinical application is indicated across Infectious disease services, septic shock bays, febrile illness clinics, and isolation units.

Limitations & Contraindications

Timely administration of empiric antibiotic therapy in suspected septic shock must never be delayed for score tabulation.

Clinical Pearls & Action Plan

Blood and site-specific microbiological cultures should be secured prior to administering broad-spectrum antimicrobials.

Formula & Variables:

Sum of points from: Age ≥65 (+1), Treatment with Systemic Antibiotics (+2), Leukocytosis >15,000/μL (+1), Albumin <2.5 g/dL (+1), Serum Creatinine >1.5× baseline (+1)

Input Parameters

NameTypeRequiredDescription
age_65_or_olderbooleanYesPatient is 65 years of age or older
systemic_antibioticsbooleanYesPatient is currently on systemic antibiotic therapy (other than for C. diff treatment)
leukocytosisbooleanYesWhite blood cell count greater than 15,000 cells per microliter
low_albuminbooleanYesSerum albumin level less than 2.5 g/dL (25 g/L)
elevated_creatininebooleanYesSerum creatinine level greater than 1.5 times the baseline/normal value

Score Interpretation & Guidance

RangeStageDescription
0–2—Good response to vancomycin therapy expected. Low risk of treatment failure.
3–6—Poor response to vancomycin therapy expected. High risk of treatment failure.

Evidence-Based References (EBM)

  • Miller MA, Louie T, Mullane K, Weiss K, Lentnek A, Golan Y, et al. Derivation and validation of a simple clinical bedside score (ATLAS) for Clostridium difficile infection which predicts response to vancomycin therapy. BMC Infect Dis. 2013;13:148.PMID: 23547790
  • Cohen SH, Gerding DN, Johnson S, Kelly CP, Loo VG, McDonald LC, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol. 2010;31(5):431-55.PMID: 20307191

Related calculators